Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Status Completed

Clinical Trial Summary

The purpose of this study is to assess off-label use of loteprednol etabonate 0.25% ophthalmic suspension (Eysuvis) for prevention of immunologic rejection in the first year after Descemet membrane endothelial keratoplasty (DMEK). Topical corticosteroids have long been the mainstay for preventing and treating cornea transplant rejection although none are specifically approved for this purpose. The rates of immunologic rejection episodes and steroid-induced ocular hypertension will be compared with the respective rates observed in earlier studies with prednisolone acetate 1% suspension, loteprednol etabonate 0.5% gel, and fluorometholone 0.1% suspension after DMEK.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05136443
Study type	Interventional
Source	Price Vision Group
Contact
Status	Completed
Phase	Phase 4
Start date	November 23, 2021
Completion date	September 5, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05139771` - EndoArt® Implantation in Subjects With Chronic Corneal Edema	N/A
Enrolling by invitation	`NCT05956535` - Air Optix® Night and Day® Aqua Therapeutic Wear
Completed	`NCT02332109` - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy	N/A
Completed	`NCT04498169` - A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy	Phase 2
Active, not recruiting	`NCT06041256` - A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)	Phase 1/Phase 2
Completed	`NCT04521140` - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery	Phase 4
Completed	`NCT01998568` - The Intraocular Pressure Measured by Different Tonometers in Corneal Edema	N/A
Recruiting	`NCT04191629` - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT04975971` - A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
Completed	`NCT05309135` - A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction	Phase 1
Completed	`NCT01853696` - Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty	Phase 4
Completed	`NCT01244334` - Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.	Phase 4
Completed	`NCT05891106` - AONDA Therapeutic Indication Study I
Active, not recruiting	`NCT04894110` - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT01387620` - Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%	Phase 4
Completed	`NCT00346138` - A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema	N/A
Completed	`NCT05271058` - Effect of Intracameral Steroids During Phacoemulsification on the Cornea	Phase 3
Recruiting	`NCT05626478` - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery	Phase 4
Completed	`NCT01890252` - Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema	N/A
Not yet recruiting	`NCT00800423` - Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema	Phase 3